Alfaisal Library

Your cart is empty.
Normal view MARC view ISBD view

Practical guide to obesity medicine / Jolanta Urszula Weaver.

Contributor(s): Weaver, Jolanta Urszula [editor.] | ScienceDirect eBooks.
Publisher: St. Louis, Missouri : Elsevier, ©2018Copyright date: ©2018Description: 347 p: illustrations.Content type: text Media type: computer Carrier type: online resourceISBN: 9780323485593.Subject(s): Obesity | Obesity -- Treatment | Obesity -- Surgery | HEALTH & FITNESS / Diseases / General | MEDICAL / Clinical Medicine | MEDICAL / Diseases | MEDICAL / Evidence-Based Medicine | MEDICAL / Internal Medicine | Obesity | Obesity -- Surgery | Obesity -- Treatment | Obesity Management | Obesity -- therapy | Obesity -- surgeryGenre/Form: Electronic books. | Print books.
Contents:
""Front Cover""; ""Practical Guide to Obesity Medicine""; ""Practical Guide to Obesity Medicine""; ""Copyright""; ""List of Contributors""; ""Preface: Does â#x80;#x9C;Benign Obesityâ#x80;#x9D; Exist?""; ""Contents""; ""I -- THE SIZE OF THE PROBLEM""; ""1 -- The Global Problem of Obesity""; ""INTRODUCTION""; ""DEFINITION OF OBESITY""; ""OBESITY RATES WORLDWIDE""; ""THE OBESITY EPIDEMIC AND URBANIZATION""; ""CHILDHOOD OBESITY""; ""THE BARKER HYPOTHESIS AND OBESITY""; ""LEAST DEVELOPED COUNTRIES AND OBESITY""; ""CONCLUSION""; ""REFERENCES""; ""2 -- Health Economics of Obesity""; ""BACKGROUND""
""INDIVIDUAL CHOICES AND BEHAVIOR""""COSTS OF OBESITY""; ""Individual Level""; ""Societal Level""; ""Healthcare System""; ""PREDICTIONS AND MODELING""; ""POLICY IMPLICATIONS""; ""Prevention Versus Treatment""; ""CONCLUSIONS""; ""REFERENCES""; ""II HORMONES AND WEIGHT PROBLEMS""; ""3 -- Glucagon-Like Peptide 1 and Human Obesity""; ""INTRODUCTION""; ""GLUCAGON-LIKE PEPTIDE 1 PHYSIOLOGY""; ""Synthesis Secretion and Degradation""; ""Role in Energy Balance""; ""GLUCAGON-LIKE PEPTIDE 1 AND THE REGULATION OF ENERGY BALANCE IN MAN""
""Mediators of Glucagon-Like Peptide 1â#x80;#x93;Induced Negative Energy Balance in Man""""Gastric mechanoreceptors""; ""Incretin effect""; ""Ghrelin""; ""Interactions with central controllers of the energy balance equation""; ""GLUCAGON-LIKE PEPTIDE 1 IN THE PATHOPHYSIOLOGY OF CLINICAL OBESITY""; ""Functional Glucagon-Like Peptide 1 Deficits as a Risk Factor Toward the Obesity Phenotype""; ""Monogenic obesity""; ""Polygenic obesity""; ""Obesity as a Risk Factor Toward Functional Glucagon-Like Peptide 1 Deficits""; ""Postâ#x80;#x93;oral glucose tolerance test glucagon-like peptide 1 secretory responses""
""In vivo neuroimaging and self-assessments of appetite""""Target organ hyposensitivity""; ""Interactions with peripheral efferents of the energy balance equation""; ""Insulin. The most extensively studied of physiologic role of GLP-1 is as an insulin secretagogue (reviewed in Ref. 80). Hyperins...""; ""Leptin. Leptin acts as a satiety signal governing long-term energy balance. Increased BMI has been shown to be positively correl...""; ""Ghrelin. Released preprandially, the orexigenic hormone ghrelin promotes meal initiation and increases food intake. It has also ...""
""Interactions with the central controllers of energy balance""""GLUCAGON-LIKE PEPTIDE 1 IN THE PHARMACOTHERAPY OF CLINICAL OBESITY""; ""Glucagon-like peptide 1 agonists""; ""Roux-en-y gastric bypass""; ""Liraglutide 3mg""; ""Glucagon-Like Peptide 1 Agonism in the Clinic""; ""Cost-benefit of 3mg liraglutide as an antiobesity agent""; ""Treatment period. Follow-up period (FUP) assessments in the SCALE Maintenance144,145 and SCALE Diabetes146 trials suggest that w...""
Summary: Get a quick, expert overview of the many key facets of obesity management with this concise, practical resource by Dr. Jolanta Weaver. Ideal for any health care professional who cares for patients with a weight problem. This easy-to-read reference addresses a wide range of topics - including advice on how to "unpack" the behavioral causes of obesity in order to facilitate change, manage effective communication with patients suffering with weight problems and future directions in obesity medicine.
    average rating: 0.0 (0 votes)
Current location Call number Status Date due Barcode Item holds
On Shelf RC628 .P73 2018 (Browse shelf) Available AU00000000016090
Total holds: 0

Includes bibliographical references and index.

""Front Cover""; ""Practical Guide to Obesity Medicine""; ""Practical Guide to Obesity Medicine""; ""Copyright""; ""List of Contributors""; ""Preface: Does â#x80;#x9C;Benign Obesityâ#x80;#x9D; Exist?""; ""Contents""; ""I -- THE SIZE OF THE PROBLEM""; ""1 -- The Global Problem of Obesity""; ""INTRODUCTION""; ""DEFINITION OF OBESITY""; ""OBESITY RATES WORLDWIDE""; ""THE OBESITY EPIDEMIC AND URBANIZATION""; ""CHILDHOOD OBESITY""; ""THE BARKER HYPOTHESIS AND OBESITY""; ""LEAST DEVELOPED COUNTRIES AND OBESITY""; ""CONCLUSION""; ""REFERENCES""; ""2 -- Health Economics of Obesity""; ""BACKGROUND""

""INDIVIDUAL CHOICES AND BEHAVIOR""""COSTS OF OBESITY""; ""Individual Level""; ""Societal Level""; ""Healthcare System""; ""PREDICTIONS AND MODELING""; ""POLICY IMPLICATIONS""; ""Prevention Versus Treatment""; ""CONCLUSIONS""; ""REFERENCES""; ""II HORMONES AND WEIGHT PROBLEMS""; ""3 -- Glucagon-Like Peptide 1 and Human Obesity""; ""INTRODUCTION""; ""GLUCAGON-LIKE PEPTIDE 1 PHYSIOLOGY""; ""Synthesis Secretion and Degradation""; ""Role in Energy Balance""; ""GLUCAGON-LIKE PEPTIDE 1 AND THE REGULATION OF ENERGY BALANCE IN MAN""

""Mediators of Glucagon-Like Peptide 1â#x80;#x93;Induced Negative Energy Balance in Man""""Gastric mechanoreceptors""; ""Incretin effect""; ""Ghrelin""; ""Interactions with central controllers of the energy balance equation""; ""GLUCAGON-LIKE PEPTIDE 1 IN THE PATHOPHYSIOLOGY OF CLINICAL OBESITY""; ""Functional Glucagon-Like Peptide 1 Deficits as a Risk Factor Toward the Obesity Phenotype""; ""Monogenic obesity""; ""Polygenic obesity""; ""Obesity as a Risk Factor Toward Functional Glucagon-Like Peptide 1 Deficits""; ""Postâ#x80;#x93;oral glucose tolerance test glucagon-like peptide 1 secretory responses""

""In vivo neuroimaging and self-assessments of appetite""""Target organ hyposensitivity""; ""Interactions with peripheral efferents of the energy balance equation""; ""Insulin. The most extensively studied of physiologic role of GLP-1 is as an insulin secretagogue (reviewed in Ref. 80). Hyperins...""; ""Leptin. Leptin acts as a satiety signal governing long-term energy balance. Increased BMI has been shown to be positively correl...""; ""Ghrelin. Released preprandially, the orexigenic hormone ghrelin promotes meal initiation and increases food intake. It has also ...""

""Interactions with the central controllers of energy balance""""GLUCAGON-LIKE PEPTIDE 1 IN THE PHARMACOTHERAPY OF CLINICAL OBESITY""; ""Glucagon-like peptide 1 agonists""; ""Roux-en-y gastric bypass""; ""Liraglutide 3mg""; ""Glucagon-Like Peptide 1 Agonism in the Clinic""; ""Cost-benefit of 3mg liraglutide as an antiobesity agent""; ""Treatment period. Follow-up period (FUP) assessments in the SCALE Maintenance144,145 and SCALE Diabetes146 trials suggest that w...""

Owing to Legal Deposit regulations this resource may only be accessed from within National Library of Scotland on library computers. For more information contact enquiries@nls.uk. StEdNL

Get a quick, expert overview of the many key facets of obesity management with this concise, practical resource by Dr. Jolanta Weaver. Ideal for any health care professional who cares for patients with a weight problem. This easy-to-read reference addresses a wide range of topics - including advice on how to "unpack" the behavioral causes of obesity in order to facilitate change, manage effective communication with patients suffering with weight problems and future directions in obesity medicine.

Elsevier ScienceDirect All Books

Copyright © 2020 Alfaisal University Library. All Rights Reserved.
Tel: +966 11 2158948 Fax: +966 11 2157910 Email: librarian@alfaisal.edu